Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Italian introduction for CellCept

Nov. 15, 1996

Oral tolerance therapy for transplant rejection from AutoImmune to enter clinic

Nov. 15, 1996

Aquila's pneumococcal immunotherapeutic enters clinical trials

Nov. 15, 1996

Lilly to manufacture SangStat generic immunosuppressant

Nov. 15, 1996

ImmuLogic's Allervax products available for licensing

Nov. 8, 1996

FDA advisory committee deems ACEL-IMUNE safe and effective for use in infants

Nov. 8, 1996

ImClone licenses NIH patent for stem cell and gene therapy

Nov. 8, 1996

Bacterial meningitis virtually eliminated in U.S. following introduction of Hib vaccine

Nov. 8, 1996

Novel DNA vaccine induces immune response to HSV-2

Nov. 1, 1996

StressGen's core technology receives patent protection

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...